Because the median survival of mice with αKO/CD80KO+shB2m tumors (87.5 days) was much longer than that of mice with WT KPC tumors (16 days), we suspect that additional Pik3ca-regulated immune modulators, perhaps including cytokines, contribute to tumor immunogenicity. This evidence concerns the gene PIK3CA and neoplasm.